Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

[A decade of biologics in dermatology].

Wozel G, Meurer M.

Hautarzt. 2012 Apr;63 Suppl 1:53-8. doi: 10.1007/s00105-011-2296-5. Review. German.

PMID:
22543947
[PubMed - indexed for MEDLINE]
2.

Long-term efficacy of biologics in dermatology.

Castelo-Soccio L, Van Voorhees AS.

Dermatol Ther. 2009 Jan-Feb;22(1):22-33. doi: 10.1111/j.1529-8019.2008.01213.x. Review.

PMID:
19222514
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Off-label uses of biologic agents in dermatology: a 2006 update.

Kerns MJ, Graves JE, Smith DI, Heffernan MP.

Semin Cutan Med Surg. 2006 Dec;25(4):226-40. Review.

PMID:
17174843
[PubMed - indexed for MEDLINE]
4.

[Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab].

Guhl G, Díaz-Ley B, Fernández-Herrera J.

Actas Dermosifiliogr. 2008 Jan-Feb;99(1):5-33. Review. Spanish.

PMID:
18206084
[PubMed - indexed for MEDLINE]
5.

Non-psoriatic dermatologic uses of monoclonal antibody therapy.

Sockolov ME, Alikhan A, Zargari O.

J Dermatolog Treat. 2009;20(6):319-27. doi: 10.3109/09546630902936778. Review.

PMID:
19954387
[PubMed - indexed for MEDLINE]
6.

[Biologics in skin diseases other than psoriasis].

Gniadecki R, Skov L.

Ugeskr Laeger. 2008 Jun 9;170(24):2126-8. Danish.

PMID:
18565293
[PubMed - indexed for MEDLINE]
7.

Application of the dermatology life quality index in clinical trials of biologics for psoriasis.

Basra MK, Hussain S.

Chin J Integr Med. 2012 Mar;18(3):179-85. doi: 10.1007/s11655-012-1007-0. Epub 2012 Apr 2. Review.

PMID:
22466941
[PubMed - indexed for MEDLINE]
8.

[Biological dermatologic agents. The Danish Society of Dermatology].

Iversen L, Kragballe K; Dansk Dermatologisk Selskab.

Ugeskr Laeger. 2007 Mar 19;169(12):1100. Danish. No abstract available.

PMID:
17394811
[PubMed - indexed for MEDLINE]
9.

[A range of targeted treatments using monoclonal antibodies in dermatology. Current and future practice].

Piérard-Franchimont C, Quatresooz P, Paquet P, Nikkels AF, Piérard GE.

Rev Med Liege. 2009 May-Jun;64(5-6):334-8. French.

PMID:
19642470
[PubMed - indexed for MEDLINE]
10.

Biologics in atopic dermatitis.

Taïeb A, Seneschal J, Mossalayi MD.

J Dtsch Dermatol Ges. 2012 Mar;10(3):174-8. doi: 10.1111/j.1610-0387.2011.07760.x. Epub 2011 Aug 3. Review.

PMID:
21812930
[PubMed - indexed for MEDLINE]
Free Article
11.

Cytokine blocking agents in dermatology.

Williams JD, Griffiths CE.

Clin Exp Dermatol. 2002 Oct;27(7):585-90. Review.

PMID:
12464154
[PubMed - indexed for MEDLINE]
12.

From conventional to cutting edge: the new era of biologics in treatment of psoriasis.

Tzu J, Kerdel F.

Dermatol Ther. 2008 Mar-Apr;21(2):131-41. doi: 10.1111/j.1529-8019.2008.00180.x. Review.

PMID:
18394087
[PubMed - indexed for MEDLINE]
13.

Biologics for psoriasis: current evidence and future use.

Griffiths CE.

Br J Dermatol. 2012 Nov;167 Suppl 3:1-2. doi: 10.1111/j.1365-2133.2012.11207.x. No abstract available.

PMID:
23082809
[PubMed - indexed for MEDLINE]
14.

Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.

Inzinger M, Heschl B, Weger W, Hofer A, Legat FJ, Gruber-Wackernagel A, Tilz H, Salmhofer W, Quehenberger F, Wolf P.

Br J Dermatol. 2011 Sep;165(3):640-5. doi: 10.1111/j.1365-2133.2011.10396.x. Epub 2011 Jul 11.

PMID:
21564068
[PubMed - indexed for MEDLINE]
15.

Infliximab in dermatological treatment: beyond psoriasis.

Rigopoulos D, Korfitis C, Gregoriou S, Katsambas AD.

Expert Opin Biol Ther. 2008 Jan;8(1):123-33. Review.

PMID:
18081542
[PubMed - indexed for MEDLINE]
16.

Biosimilars in dermatology: starting with infliximab.

Puig L.

Actas Dermosifiliogr. 2013 Apr;104(3):175-80. doi: 10.1016/j.ad.2012.10.002. Epub 2012 Dec 6. English, Spanish. No abstract available.

PMID:
23218608
[PubMed - indexed for MEDLINE]
17.

The use of cyclosporine in dermatology: part I.

Amor KT, Ryan C, Menter A.

J Am Acad Dermatol. 2010 Dec;63(6):925-46; quiz 947-8. doi: 10.1016/j.jaad.2010.02.063. Review.

PMID:
21093659
[PubMed - indexed for MEDLINE]
18.

Long-term safety of biologics in dermatology.

Lima XT, Seidler EM, Lima HC, Kimball AB.

Dermatol Ther. 2009 Jan-Feb;22(1):2-21. doi: 10.1111/j.1529-8019.2008.01212.x. Review.

PMID:
19222513
[PubMed - indexed for MEDLINE]
19.

[Possibilities and limits for treating psoriasis with biologics. Case reports].

Süss A, Colsman A, Simon JC, Sticherling M.

Hautarzt. 2009 Jan;60(1):51-6. doi: 10.1007/s00105-008-1571-6. German.

PMID:
18712323
[PubMed - indexed for MEDLINE]
20.

Developments in systemic immunomodulatory therapy for psoriasis.

Berger EM, Gottlieb AB.

Curr Opin Pharmacol. 2007 Aug;7(4):434-44. Epub 2007 Jul 12. Review.

PMID:
17627886
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk